Hercules CapitalHTGC
About: Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
Employees: 100
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
83% more repeat investments, than reductions
Existing positions increased: 143 | Existing positions reduced: 78
2% more capital invested
Capital invested by funds: $759M [Q4 2024] → $774M (+$14.9M) [Q1 2025]
0.74% more ownership
Funds ownership: 22.55% [Q4 2024] → 23.29% (+0.74%) [Q1 2025]
0% more funds holding in top 10
Funds holding in top 10: 4 [Q4 2024] → 4 (+0) [Q1 2025]
3% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 38
3% less funds holding
Funds holding: 329 [Q4 2024] → 320 (-9) [Q1 2025]
25% less call options, than puts
Call options by funds: $11.3M | Put options by funds: $15.1M
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
Wells Fargo Finian O'Shea | 6%upside $19 | Overweight Maintained | 28 Apr 2025 |
UBS Vilas Abraham | 0%upside $18 | Neutral Maintained | 17 Apr 2025 |
Keefe, Bruyette & Woods Paul Johnson | 14%upside $21 | Outperform Maintained | 8 Apr 2025 |
Piper Sandler Crispin Love | 11%upside $20 | Overweight Maintained | 8 Apr 2025 |
Financial journalist opinion
Based on 9 articles about HTGC published over the past 30 days









